VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Stock Chart & Stock Price History GBX 15.77 +0.28 (+1.81%) As of 08/20/2025 10:54 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsBuy This Stock VanEck Bionic Engineering UCITS ETF A Acc Stock Price Performance The VanEck Bionic Engineering UCITS ETF A Acc (CYBG) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 1.18%, with a year-to-date return of -4.39%. In the past month, the stock has increased 4.14%, reflecting recent market activity. As of the latest close, VanEck Bionic Engineering UCITS ETF A Acc traded at GBX 15.77 with a market cap of £226.25 million and volume of 63 shares. Receive CYBG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VanEck Bionic Engineering UCITS ETF A Acc and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.52%1 Month Performance+4.14%3 Month Performance+0.52%Year-To-Date Performance-4.39%1 Year Performance-1.18% CYBG Stock Chart for Thursday, August, 21, 2025 CYBG Chart by TradingView VanEck Bionic Engineering UCITS ETF A Acc Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/20/2025GBX 15.54GBX 15.77+1.48%GBX 15.77GBX 15.7763 shs£226.25 million08/19/2025GBX 15.54GBX 15.54GBX 15.54GBX 15.54240 shs£222.95 million08/18/2025GBX 15.39GBX 15.54+1.01%GBX 15.54GBX 15.54240 shs£222.95 million08/15/2025GBX 15.24GBX 15.24GBX 15.24GBX 15.18240 shs£218.55 million08/14/2025GBX 15.24GBX 15.24GBX 15.24GBX 15.18240 shs£218.55 million08/13/2025GBX 15.24GBX 15.24GBX 15.24GBX 15.18240 shs£218.55 million08/12/2025GBX 15.24GBX 15.24GBX 15.24GBX 15.18240 shs£218.55 million08/11/2025GBX 15.24GBX 15.24GBX 15.24GBX 15.18240 shs£218.55 million08/08/2025GBX 15.18GBX 15.18GBX 15.18GBX 15.18240 shs£217.70 million08/07/2025GBX 15.16GBX 15.18+0.13%GBX 15.18GBX 15.18240 shs£217.70 million Get the Latest News and Ratings for CYBG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VanEck Bionic Engineering UCITS ETF A Acc and its competitors with MarketBeat's FREE daily newsletter. 08/06/2025GBX 15.16GBX 15.16GBX 15.50GBX 15.16202 shs£217.41 million08/05/2025GBX 15.16GBX 15.16GBX 15.50GBX 15.16202 shs£217.41 million08/04/2025GBX 15.16GBX 15.16GBX 15.50GBX 15.16202 shs£217.41 million08/01/2025GBX 15.45GBX 15.45GBX 15.50GBX 15.45252 shs£221.60 million07/31/2025GBX 15.55GBX 15.45-0.67%GBX 15.50GBX 15.45252 shs£221.60 million07/30/2025GBX 15.55GBX 15.55GBX 15.55GBX 15.17230 shs£223.09 million07/29/2025GBX 15.55GBX 15.55GBX 15.55GBX 15.17230 shs£223.09 million07/28/2025GBX 15.55GBX 15.55GBX 15.55GBX 15.17230 shs£223.09 million07/23/2025GBX 14.99GBX 15.06+0.45%GBX 15.17GBX 15.06230 shs£216.06 million07/21/2025GBX 15.15GBX 15.15GBX 15.17GBX 15.15230 shs£217.25 million Related Companies Standard Life Private Equity Trust Stock Chart Schroder Oriental Income Stock Chart Bluefield Solar Income Fund Stock Chart Polar Capital Stock Chart European Assets Trust Stock Chart Receive CYBG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VanEck Bionic Engineering UCITS ETF A Acc and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CYBG) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Bionic Engineering UCITS ETF A Acc Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Bionic Engineering UCITS ETF A Acc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access